MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • In-stock with prices
  • Research applications
  • Catalog data snapshot
  • Patent compound sourcing
  • Request Quote

Categories

  • Protected amines
  • Boronic acids
  • Fluorinated building blocks
  • Heterocycles
  • Pharmaceutical intermediates
  • Custom synthesis

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Returns & Refunds
  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 2135-17-3/Safety Reference
CAS 2135-17-3Preliminary Safety ReferenceNot a supplier-issued SDSSupplier SDS by request

CAS 2135-17-3 Safety Reference and Supplier SDS Request

Flumethasone

Back to CAS detail

Preliminary reference disclaimer

This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.

Documentation status

Preliminary safety reference

Available

Supplier-issued SDS

Available by request

COA

Available by RFQ / lot confirmation

Transport classification

Requires shipment review

Identity

CAS Number

2135-17-3

Chemical name

Flumethasone

Molecular formula

C22H28F2O5

Molecular weight

410.5 g/mol

Synonyms

Flumetasone; Flucort; Flumetasona; Flumetasonum; 6alpha,9-Difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione; U-10,974; Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,17,21-trihydroxy-16-methyl-, (6alpha,11beta,16alpha)-; Fluorodexamethasone; Bimasone; Flucort Tablets; Anaprime Suspension; flumethasoni pivalas

InChIKey

WXURHACBFYSXBI-GQKYHHCASA-N

PubChem CID

16490

Hazard / GHS Reference

Signal word

Warning

Catalog reference cue; confirm supplier documentation before use.

Hazard statements

H302

Catalog reference cue; confirm supplier documentation before use.

Handling & PPE

  • Keep container tightly closed and dry. Store in a well-ventilated place. Recommended storage conditions: sealed and dry, 2-8°C
  • If exposed to a harmful environment, use a P95 (US) or P1 (EU, UK 143) particulate respirator. For higher level of protection, use an OV/AG/P99 (US) or ABEK-P2 (EU, UK 143) gas mask. Respirators must be tested and approved by government standards such as NIOSH (US) or CEN (EU).
  • Dispose of the remaining and non-recyclable solution to a licensed company. Contact a professional agency with a waste disposal license to handle this substance. Burn in a chemical incinerator with post-combustion treatment and washing. Contaminated packaging. Dispose of as unutilized product.

First Aid / Accidental Release

  • Do not give anything to an unconscious person. Rinse mouth with water. Consult a physician.
  • If inhaled, move the patient to fresh air. If breathing stops, perform artificial respiration. Consult a physician.
  • Rinse with plenty of water for at least 15 minutes and consult a physician.
  • Wash with soap and plenty of water. Consult a physician.
  • Do not generate dust when collecting and disposing. Sweep and shovel up. Place in a suitable closed container for disposal.
  • Use personal protective equipment and emergency procedures. Avoid dust generation. Avoid inhalation of vapors, mists or gases. Ensure adequate ventilation. Evacuate personnel to a safe area. Avoid inhalation of dust. See
  • Do not allow the product to enter the sewer.
  • Dispose of the remaining and non-recyclable solution to a licensed company. Contact a professional agency with a waste disposal license to handle this substance. Burn in a chemical incinerator with post-combustion treatment and washing. Contaminated packaging. Dispose of as unutilized product.

Firefighting / Stability

  • If necessary, wear a self-contained breathing apparatus for firefighting.
  • Reactivity
  • Carbon monoxide, carbon dioxide, hydrogen fluoride

Physical and Chemical Reference

Melting Point

219.0 °C

Catalog reference value; verify against supplier SDS before use.

Water Solubility

0.392 mg/L

Catalog reference value; verify against supplier SDS before use.

XLogP

1.9

Catalog reference value; verify against supplier SDS before use.

Transport / Shipment Review

Shipment review

Shipment details require review before fulfillment.

Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.

  • Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.

Need supplier documentation?

Request through MolGraph:

  • Supplier-issued SDS
  • COA
  • Purity and pack size confirmation
  • Availability and lead time review
  • Shipment documentation review

Catalog-Specific Reference Cues

  • Flumethasone (CAS 2135-17-3) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C22H28F2O5 and molecular weight 410.50 g/mol.
  • Intended for research-stage medicinal chemistry and intermediate synthesis workflows.

Related catalog entries

Related public CAS links are not available for this reference page.

MolGraph Preliminary Safety Reference - Not a supplier-issued SDS. This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.